Retractable Technologies (RVP)
XASE:RVP
Top Page
Retractable Technologies
(NYSE MKT:RVP)
Select Model
Select Model
Rating:43Neutral
Price Target:
$0.65
▼(-11.37% Downside)
Action:ReiteratedDate:03/28/26
The score is driven primarily by deteriorating fundamentals—multi-year losses, weakened revenue/margins, and recent cash burn—partly mitigated by low leverage. Technicals remain soft with the stock below longer-term averages, and valuation is constrained by negative earnings. Corporate updates add risk due to ongoing tariff-related cost pressure and low cash.
Positive Factors
Low leverage / strong balance sheet
Very low debt and a relatively sizeable equity base provide durable financial flexibility despite operating losses. Low leverage reduces bankruptcy and refinancing risk, allowing the company to fund operations, manage tariffs, or pursue restructuring without immediate debt pressure.
Negative Factors
Sustained losses and margin erosion
Multi-year swing from prior profitability to sustained net losses and compressed or negative gross margins signals structural cost or pricing issues. Persistent negative margins undermine reinvestment capacity, weaken returns, and make a durable earnings recovery more difficult without significant operational change.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / strong balance sheet
Very low debt and a relatively sizeable equity base provide durable financial flexibility despite operating losses. Low leverage reduces bankruptcy and refinancing risk, allowing the company to fund operations, manage tariffs, or pursue restructuring without immediate debt pressure.
Read all positive factors
Retractable Technologies (RVP) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$21.49M
Dividend YieldN/A
Average Volume (3M)153.51K
Price to Earnings (P/E)―
Beta (1Y)0.46
Revenue Growth-0.95%
EPS Growth58.17%
CountryUS
Employees221
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)-0.08
Shares Outstanding29,937,159
10 Day Avg. Volume341,920
30 Day Avg. Volume153,511
Financial Highlights & Ratios
PEG Ratio-0.25
Price to Book (P/B)0.31
Price to Sales (P/S)0.60
P/FCF Ratio-3.04
Enterprise Value/Market Cap0.90
Enterprise Value/Revenue0.50
Enterprise Value/Gross Profit409.63
Enterprise Value/Ebitda-2.18
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Retractable Technologies Business Overview & Revenue Model
Company Description
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers Vanis...
How the Company Makes Money
Retractable Technologies makes money primarily by selling its safety medical devices (especially retractable safety syringes and related injection/safety needle products) to healthcare customers through a mix of direct sales and distribution chann...
Retractable Technologies Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
74
Positive
Cash Flow
27
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 38.27M | 33.05M | 43.60M | 94.82M | 188.38M |
| Gross Profit | 47.05K | -1.03M | 9.11M | 28.25M | 95.35M |
| EBITDA | -12.45M | 4.17M | -1.24M | 9.94M | 76.44M |
| Net Income | -12.57M | -11.89M | -7.01M | 5.08M | 56.06M |
Balance Sheet | |||||
| Total Assets | 142.63M | 160.72M | 179.67M | 210.74M | 213.15M |
| Cash, Cash Equivalents and Short-Term Investments | 36.97M | 44.56M | 47.29M | 49.38M | 42.43M |
| Total Debt | 365.28K | 1.23M | 1.54M | 2.92M | 4.24M |
| Total Liabilities | 68.26M | 73.55M | 80.38M | 104.21M | 113.98M |
| Stockholders Equity | 74.38M | 87.17M | 99.29M | 106.54M | 99.17M |
Cash Flow | |||||
| Free Cash Flow | -7.60M | -13.00M | 1.91M | -61.95K | -25.57M |
| Operating Cash Flow | -7.06M | -11.56M | 2.77M | 16.77M | 32.79M |
| Investing Cash Flow | 5.98M | 3.66M | -10.76M | -31.20M | -63.04M |
| Financing Cash Flow | -567.32K | -535.43K | 941.64K | 4.99M | 41.84M |
Retractable Technologies Technical Analysis
Positive
0.73
Price Trends
0.69
Positive
0.74
Negative
0.77
Negative
Market Momentum
<0.01
Negative
55.97
Neutral
61.11
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RVP, the sentiment is Positive. The current price of 0.73 is above the 20-day moving average (MA) of 0.70, above the 50-day MA of 0.69, and below the 200-day MA of 0.77, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 55.97 is Neutral, neither overbought nor oversold. The STOCH value of 61.11 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RVP.
Retractable Technologies Risk Analysis
Retractable Technologies disclosed 17 risk factors in its most recent earnings report. Retractable Technologies reported the most risks in the "Macro & Political" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Retractable Technologies Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | $211.53M | -2.25 | -18.58% | ― | -43.95% | -620.21% | |
47 Neutral | $189.64M | -9.67 | -191.60% | ― | 19.61% | -3.42% | |
46 Neutral | $21.96M | -3.92 | -164.78% | ― | 0.59% | -39.76% | |
46 Neutral | $155.56M | -5.36 | -178.57% | ― | 30.55% | -340.19% | |
43 Neutral | $21.49M | -1.84 | -8.13% | ― | -0.95% | 58.17% |
* Healthcare Sector Average
RVP
Retractable Technologies
0.72
0.04
5.74%
OSUR
Orasure Technologies
3.06
0.13
4.44%
STXS
Stereotaxis
1.95
0.29
17.47%
MLSS
Milestone Scientific
0.27
-0.63
-69.78%
SMTI
Sanara MedTech
16.97
-12.08
-41.58%
STSS
Sharps Technology, Inc.
1.67
-5.83
-77.73%
Retractable Technologies Corporate Events
Business Operations and StrategyDividendsFinancial Disclosures
Retractable Technologies Declares Preferred Dividend Amid Tariff Pressures
Negative
Mar 27, 2026
Retractable Technologies, Inc., a maker of safety syringes, needles, and related medical devices, reported that revenues for 2025 rose 15.8% to approximately $38.3 million, driven by higher domestic VanishPoint and EasyPoint needle sales and a 64....
Dividends
Retractable Technologies Declares Dividend on Convertible Preferred Shares
Positive
Dec 30, 2025
On December 30, 2025, Retractable Technologies announced that it declared a dividend for holders of its Series II and Series III Class B Convertible Preferred Stock. The dividend declaration affects this specific class of preferred shareholders an...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.